FOXO4-DRI

Description

FOXO4-DRI Peptide Vial 10mg Malta

This product is intended for research purposes only. To be used by trained professionals only.

FOXO4-DRI is a peptide antagonist intended to reverse ageing effects in animal subjects through selective induction of apoptosis of senescent cells. The FOXO4 gene also helps with tumour suppressant activity in addition to reversing symptoms of ageing. Thus it may encourage longevity in older people and even decrease dementia [1].

DHT is the primary cause of hair loss. This molecule created by dihydrotestosterone, produced by the body as a male hormone. In the scalp, DHT travels down the hair follicle shaft and attaches itself to a dikaryon-homologous protein. This protein breaks off into two strands, forming what we know as the hair follicle’s DHT-inhibiting enzyme. DHT functions to slow down hair growth and found at a hair follicle’s surface. DHT becomes a problem in the scalp because it “bumps” a minor protein named FHRP. Which in turn then attaches itself to the core of hair follicles, the roots. This causes hair loss. When DHT attaches itself to FHRP, it stops hair from growing and starts hair thinning. 

Research has suggested on mice and rats, with FOXO4-DRI, there is an increase in the blood supply to the scalp. The hair follicles benefit as well, as there is an increased supply of nutrients and growth hormones that make them thrive. As a result, the proteins in the follicles enlarge and the DHT-blocking enzyme functions to reduce hair loss. Preventing hair thinning and hair loss.

Unlike some other molecules that have protective activity against DHT, such as melanocortin receptors. FOXO4-DRI’s designed to stop DHT. There are many research use show this compound to be a beneficial product for treating hair loss. This peptide in studies has shown promising results to help with hair loss treatment.

Testicular microenvironment and age-related testosterone insufficiency were alleviated by the effects of FOX04-DRI on naturally aged mice. Men with late-onset hypogonadism may benefit therapeutically from FOXO4-DRI, according to these findings [2].

References:

[1] https://www.ncbi.nlm.nih.gov/pmc/ articles/PMC5556182/

[2] https://pubmed.ncbi.nlm.nih.gov/ 31959736/

ALL CONTENT AND PRODUCT INFORMATION AVAILABLE ON THIS WEBSITE IS FOR EDUCATIONAL PURPOSES ONLY.

DISCLAIMER: These products are intended solely as a research chemical only. This classification allows for their use only for research development and laboratory studies. The information available on our Malta Direct Peptides website: https://malta.direct-peptides.com is provided for educational purposes only. These products are not for human or animal use or consumption in any manner. Handling of these products should be limited to suitably qualified professionals. They are not to be classified as a drug, food, cosmetic, or medicinal product and must not be mislabelled or used as such.

Buy FOXO4-DRI online today from Malta Direct Peptides